Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193805-24-000704
Filing Date
2024-05-24
Accepted
2024-05-24 16:06:52
Documents
5

Document Format Files

Seq Description Document Type Size
1 PRE-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 e663650_s3a-immunic.htm S-3/A 270676
2 OPINION OF DENTONS US LLP e663650_ex5-1.htm EX-5.1 22709
3 CALCULATION OF FILING FEE TABLE e663650_ex107.htm EX-FILING FEES 48269
4 GRAPHIC image_001.jpg GRAPHIC 3212
5 GRAPHIC image_002.jpg GRAPHIC 21242
  Complete submission text file 0001193805-24-000704.txt   376745
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Filer) CIK: 0001280776 (see all company filings)

EIN.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-275717 | Film No.: 24984297
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)